The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of continuous zanubrutinib vs fixed-duration venetoclax in combination with obinutuzumab in treatment-naive (TN) chronic lymphocytic leukemia (CLL): A matching-adjusted indirect comparison (MAIC).
 
Talha Munir
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; AstraZeneca; BeiGene; Janssen-Cilag; Lilly; Roche; SOBI
Speakers' Bureau - Abbvie; Alexion Pharmaceuticals; AstraZeneca; Gilead Sciences; Janssen-Cilag; SOBI
Travel, Accommodations, Expenses - Abbvie; Alexion Pharmaceuticals; AstraZeneca; Janssen-Cilag
 
Keri Yang
Employment - BeOne Medicines Ltd
Leadership - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
Research Funding - BeOne Medicines Ltd
 
Leyla Mohseninejad
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Sheng Xu
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Pal Rakonczai
Research Funding - BeiGene (Inst)
 
Balazs Dobi
Research Funding - BeiGene (Inst)
 
Rhys Williams
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Nicolas Martinez-Calle
Honoraria - AbbVie; AstraZeneca; BeiGene; Janssen
Consulting or Advisory Role - AbbVie; AstraZeneca; BeiGene; CLS Behring; Takeda